98%
921
2 minutes
20
Advanced epithelial ovarian cancer (EOC) has traditionally been treated with primary debulking surgery; however, recent phase III trials have demonstrated similar survival outcomes for patients who were randomized to neoadjuvant chemotherapy followed by interval debulking (IDS) when compared to patients who underwent PDS. We sought to evaluate a cohort of patients with EOC diagnosed between 2010 and 2019 who underwent complete cytoreduction (R0-no gross residual disease) during IDS. We compared the outcomes after R0 resection via MIS versus laparotomy in IDS. The primary endpoint was overall survival (OS). Kaplan-Meier analysis and inverse probability of treatment weighting (IPTW) were used. Cases were stratified by surgical extent and within the MIS cohort by robotic assistance. Surgical outcomes (LOS, readmission rate, 30- and 90-day mortality) were also assessed. In total, 2412 patients were eligible. 624 (25.8%) underwent R0 resection via MIS. Over the study period, the MIS utilization rate increased from 12% to 36%. There was no significant difference in OS between the MIS and open cohorts (51 vs. 46 months, HR 1.1; 95% CI 0.96-1.24). 30-day and 90-day postoperative mortality rates were higher in the open group (1.6% vs. 0.8%, = 0.006) and (1.9% vs. 3.5%, = 0.003), respectively. Patients in the MIS group were less likely to undergo extensive surgery (41% vs. 53%, < 0.001). When stratified by surgical extent, no significant difference in OS was observed between MIS and laparotomy (49 vs. 44 months in the extensive surgery group and 53 vs. 50 months in the non-extensive surgery group). Within the MIS cohort, 49% of cases were performed robotically. OS did not differ significantly between robotic and conventional laparoscopic cases (52 vs. 50 months). From 2010 to 2019, there was an increase in the use of robot-assisted laparoscopy (from 6.2% to 25.5%), coinciding with a decline in the laparotomy rate (from 88.1% to 63.5%) ( = 0.008). R0 resection via MIS during IDS showed similar OS and decreased postoperative mortality compared to laparotomy. The increasing utilization of robotic assistance is associated with a decrease in the laparotomy rate.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11856761 | PMC |
http://dx.doi.org/10.3390/jcm14041164 | DOI Listing |
JSLS
September 2025
Colorectal and Minimally Invasive Surgery Specialists, Jackson Medical Group, Jackson S. Medical Center, Miami, Florida, USA. (Drs. Altamirano, Adogowa, and Lujan).
Background: Management of left-sided colorectal Grade C anastomotic leak (AL) has traditionally been managed via laparotomy. However, with the growing adoption of minimally invasive techniques, recent literature suggests that laparoscopic surgery provides a safe and viable alternative for managing Grade C leaks.
Methods: This study is a case series that consists of 7 adults that underwent laparoscopic reintervention of purulent or feculent peritonitis from left-sided colorectal AL during the period of 2016-2024 at our institution.
Arq Bras Cir Dig
September 2025
Brazilian Gastric Cancer Association - São Paulo (SP), Brazil.
Background: Gastric cancer (GC) remains a major global health problem. Despite a decline in its incidence, GC is still the third most lethal cancer worldwide.
Background: Multimodal treatment approaches are employed, including chemotherapy (CMT), radiotherapy (RDT), surgery, expanded criteria for endoscopic resection, and increased use of minimally invasive surgery.
Colorectal Cancer
August 2025
Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Introduction: Patients with functional dependence have poorer outcomes after surgery for colon cancer than those who are independent. We sought to determine how much the use of minimally invasive surgery (MIS) would reduce the impact of functional dependence on discharge home, 30-day readmission, and 30-day mortality.
Methods: We used the 2012-2020 American College of Surgeons' National Surgical Quality improvement Program data on patients who underwent colectomies for colon cancer.
Trials
August 2025
Division of Colon and Rectal Surgery, Department of Surgery, Chang Gung Memorial Hospital at Linkou, Chang Gung University, College of Medicine, Taoyuan, Taiwan.
Background: Minimally invasive surgery (MIS) has improved colorectal cancer (CRC) treatment by reducing recovery time, pain, and infection risk compared to traditional open surgery, though a mini laparotomy is still needed for specimen removal. Natural orifice specimen extraction (NOSE) offers a promising alternative by using natural body openings for extraction, potentially minimizing complications further, yet requires more evidence to confirm its safety and effectiveness over conventional methods.
Methods: This single-center randomized controlled trial at Linkou Chang-Gung Memorial Hospital includes CRC patients meeting specific eligibility criteria, randomly assigned to undergo either NOSE or conventional MIS.
Surg Endosc
August 2025
Hepatobiliary Surgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, L.go A. Gemelli 8, 00168, Rome, Italy.
Background: Incidental gallbladder cancer (iGBC) presents unique management challenges. This retrospective single-center study evaluates perioperative and long-term outcomes following oncologic revisional resection (ORR) via open and minimally invasive surgery (MIS) over a 25-year period.
Methods: Patients diagnosed T1b-T3 iGBC undergone ORR (anatomical resection of liver segments 4b-5 and regional lymphadenectomy) from January 2000 through December 2024 were included.